Female Viagra Just OK

Flibanserin, the first drug approved by the FDA to treat low sexual desire in women, is likely garner low desire for itself. The New York Times reports that researchers who analyzed eight studies involving 5,900 women concluded that treatment with the drug, now marketed as Addyi, resulted in “one-half of an additional sexually satisfying encounter per month.” No, the scientists didn’t say what “one-half” of a sexually satisfying encounter was, or which half they were talking about. The Times reports that the study results were in line with earlier results from clinical trials, which found that once women started taking the drug, they had an average of about one additional satisfying sexual encounter a month, on top of the two to three they were having already.

Share on Google Plus